Business Context and Reporting Period
This Form 6-K filing by Akso Health Group covers the month of May 2025. The report discloses a material change in executive management, specifically the resignation of the Chief Financial Officer and the appointment of a successor.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignation: Ms. Rui (Kerrie) Zhang resigned as Chief Financial Officer effective April 24, 2025, citing personal reasons with no disagreement regarding company operations.
- Appointment: Mr. Zhongliang Xie was appointed as the new Chief Financial Officer effective April 24, 2025.
- Term: Mr. Xie's appointment is for an initial term of one year, renewable for successive one-year terms.
Management Commentary and Background
Mr. Zhongliang Xie brings significant experience in accounting and auditing. He has served as General Manager of Zhongxingcai Guanghua Certified Public Accountants Shaanxi Branch since 2019 and previously held similar roles in Xi'an. He is a Chinese Certified Public Accountant (CPA), Certified Asset Appraiser, and a fellow of the International Association of Accountants (FAIA). The Company confirmed there are no family relationships between Mr. Xie and any directors and no undisclosed arrangements regarding his appointment.
Key Facts for Investor Verification
- Verify the effective date of the CFO transition (April 24, 2025).
- Confirm Mr. Zhongliang Xie's professional credentials and prior audit experience.
- Note that the resignation was stated as voluntary and unrelated to operational disputes.
- Understand that this filing contains no financial results or forward-looking guidance.